Skip to content

MCE-new for Detection of Gastric Lesions

New MCE System for Detection of Gastric Lesions

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06020859
Enrollment
30
Registered
2023-09-01
Start date
2023-08-30
Completion date
2024-11-30
Last updated
2023-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Capsule Endoscopy

Brief summary

Clinical application of magnetically controlled capsule endoscopy : a prospective self-controlled trial

Detailed description

The aim of this study is to investigate the effectiveness and safety of using a new MCE system for routine gastric examination and automatic scanning. This study is a prospective, self controlled clinical trail, which includes adult patients who plan to undergo MCE examination. Patients will undergo three different tests during the experiment: NaviEC-2000Pro Gastro Scan, NaviEC-2000Pro routine gastric examination, NaviEC-1000 routine gastric examination.

Interventions

DEVICEundergo NaviEC-2000Pro Gastro Scan mode

Patients undergo NaviEC-2000Pro Gastro Scan mode.

DEVICENaviEC-2000Pro Routine gastric examination

Patients undergo NaviEC-2000Pro Routine gastric examination mode.

DEVICENaviEC-1000 Routine gastric examination

Patients undergo NaviEC-1000 Routine gastric examination mode.

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* underwent gastric examination; * At least 18 years old; * Be able to provide informed consent.

Exclusion criteria

* With swallowing obstruction or disorders; * With known or suspected gastrointestinal obstruction, stenosis and fistula; * Have no conditions for surgery or refuse to undergo any abdominal surgery; * Be allergic to or have other known contraindication or intolerance to the drug used in the study; * With pacemakers or other electronic devices such as electronic cochlear implants, implanted magnetic metal drug infusion pumps, neurostimulators, and magnetic metal foreign bodies; * Women during pregnancy; * Currently enrolled in another clinical trial of a drug or device; * Other conditions determined by the investigator to be inappropriate for enrollment.

Design outcomes

Primary

MeasureTime frameDescription
the degree of gastric mucosal visualization2 weeksThe overall observational integrity of the gastric mucosa is based on the evaluation of the mucosal visualization of several key anatomical sites in the stomach: cardia, fundus, gastric body, gastric horn, gastric antrum and pylorus. The evaluation criteria for mucosal visualization of each site are: good : adequate observation, ≥90% of the gastric mucosa can be observed; fair : good observation, 70-90% of the gastric mucosa can be observed; poor : inadequate observation, \<70% of the gastric mucosa can be observed.

Secondary

MeasureTime frameDescription
The time of gastric examination2 weeksThe total time MCE required to complete the stomach examination
detection of lesions2 weeksThe detection of gastric lesions by MCE
Equipment operation evaluation2 weeksOperation fluency is defined as the smooth response between operation and real-time capsule shooting. Stability is defined as the stable ability to control the capsule in a fixed position; Comfort is defined as the operator's operating comfort during examination. They were all rated on a scale of 1-5, with 1 being the worst and 5 the best
Safety Assessment2 weeksNumber and incidence of device-related adverse events and serious adverse events

Contacts

Primary ContactZhuan Liao
liaozhuan@smmu.edu.cn86-21-31161004
Backup ContactYangyang Qian

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026